Literature DB >> 34245371

The prognostic role of radiotherapy and radiotherapy target in cervical lymph node metastatic squamous cell carcinoma with unknown primary: a retrospective study.

Ruidan Li1, Kai Liao2, Zhigong Wei1, Zheran Liu1, Yan He1, Jingjing Wang1, Ling He1, Xiaoli Mu1, Lianlian Yang1, Yan Huang1, Libang He3, Xingchen Peng4.   

Abstract

OBJECTIVES: Aim to analyze the effect of radiotherapy for cervical lymph node metastatic carcinoma with unknown primary (CCUP) and compare the survival benefits between Comprehensive radiotherapy and Involved Field radiotherapy.
MATERIALS AND METHODS: The patients diagnosed with CCUP between 2009 and 2019 in our institution were analyzed retrospectively. The categorical variables were tested by χ2 test. Kaplan-Meier method was used for survival analysis. Log-rank test and Cox proportional hazards regression were performed with overall survival (OS) and disease-free survival (DFS) as the primary outcome variables.
RESULTS: Of 139 patients, 64.7% (90/139) of them received radiotherapy. Of the 90 patients who underwent radiotherapy, 45.6% (41/90) received Involved Field radiotherapy and the rest 49 patients received Comprehensive radiotherapy. The median follow-up of 139 patients is 69 months. The 1-year, 3-year, and 5-year OS rates are 87%, 62%, and 39%, respectively, and the DFS rates are 73%, 45%, and 29%, respectively. Multivariate analysis of 139 patients with CCUP shows that differentiation grade, N stage, radiotherapy, and the length of the largest lymph node (DmaxLN) are the independent prognostic factors for both OS and DFS. Subgroup analysis of 90 patients who received radiotherapy shows that the Comprehensive radiotherapy group has a better OS (P < 0.001) and DFS (P < 0.001) compared with Involved Field radiotherapy.
CONCLUSION: Radiotherapy is the independent prognostic factor for CCUP. Comprehensive radiotherapy may be superior to Involved Field radiotherapy in survival benefits.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cervical lymph node metastatic carcinoma with unknown primary; Prognosis; Radiotherapy; Target delineation

Mesh:

Year:  2021        PMID: 34245371     DOI: 10.1007/s00432-021-03724-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

1.  Histopathological and immunohistochemical study of laterocervical lymph node metastases of unknown primary origin.

Authors:  Ramona Denise Mălin; Elena Ioniţă; I Osman; Carmen Aurelia Mogoantă; Luminiţa Cioroianu; S Ciolofan; F Anghelina; Mădălina Enăchescu
Journal:  Rom J Morphol Embryol       Date:  2012       Impact factor: 1.033

2.  Human papillomavirus (HPV) assays for testing fine-needle aspiration specimens in patients with head and neck squamous cell carcinoma.

Authors:  William C Faquin
Journal:  Cancer Cytopathol       Date:  2013-12-11       Impact factor: 5.284

3.  Assessing for primary oropharyngeal or nasopharyngeal squamous cell carcinoma from fine needle aspiration of cervical lymph node metastases.

Authors:  Suneal Jannapureddy; Cynthia Cohen; Stephen Lau; Jonathan J Beitler; Momin T Siddiqui
Journal:  Diagn Cytopathol       Date:  2010-11       Impact factor: 1.582

Review 4.  Management of Squamous Cancer Metastatic to Cervical Nodes With an Unknown Primary Site.

Authors:  Thomas J Galloway; John A Ridge
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

5.  Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology.

Authors:  C Grau; L V Johansen; J Jakobsen; P Geertsen; E Andersen; B B Jensen
Journal:  Radiother Oncol       Date:  2000-05       Impact factor: 6.280

Review 6.  Neck lymph node metastases from unknown primary.

Authors:  Alberto Daniele Arosio; Lorenzo Pignataro; Renato Maria Gaini; Werner Garavello
Journal:  Cancer Treat Rev       Date:  2016-12-10       Impact factor: 12.111

7.  18 F-FDG PET/CT vs. human papillomavirus, p16 and Epstein-Barr virus detection in cervical metastatic lymph nodes for identifying primary tumors.

Authors:  Gi Cheol Park; Jong-Lyel Roh; Kyung-Ja Cho; Jae Seung Kim; Mi Hyeon Jin; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Int J Cancer       Date:  2017-03-15       Impact factor: 7.396

8.  Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.

Authors:  A Ligey; J Gentil; G Créhange; X Montbarbon; P Pommier; K Peignaux; G Truc; P Maingon
Journal:  Radiother Oncol       Date:  2009-11-04       Impact factor: 6.280

9.  Oropharynx-directed ipsilateral irradiation for p16-positive squamous cell carcinoma involving the cervical lymph nodes of unknown primary origin.

Authors:  Allen M Chen; Jessica Meshman; Sophia Hsu; Taeko Yoshizaki; Elliot Abemayor; Maie St John
Journal:  Head Neck       Date:  2017-12-16       Impact factor: 3.147

Review 10.  Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.

Authors:  Barbara A Jereczek-Fossa; Jacek Jassem; Roberto Orecchia
Journal:  Cancer Treat Rev       Date:  2004-04       Impact factor: 12.111

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.